Corona in general

The results of Phase I clinical trials for two new COVID-19 vaccine candidates based on recombinant RDB proteins are reported. // 10.10.2021

A new study introduces the possibility that the inactivated polio vaccine can elicit antibodies that inhibit SARS-CoV-2 nucleic acid synthesis. // 10.10.2021

In a new study, researchers discovered that SARS-CoV-2 mutations accumulate, especially in immunocompromised patients. // 10.10.2021

A new paper discusses a new antibody with potent neutralizing activity against the ancestral SARS-CoV-2 strain, as well as newer variants of SARS-CoV-2. // 10.10.2021

A new study utilizes dynamic causal modeling to predict the effects of letting SARS-CoV-2 sweep through a largely vaccinated population. // 10.10.2021

Researchers investigated the utility of initial SARS-CoV-2 viral loads of tests performed at a Public Health testing facility regarding hospital and ICUs admissions and overall survival. // 8.10.2021

Hope for a future without fear of COVID-19 comes down to circulating antibodies and memory B cells. Unlike circulating antibodies, which peak soon after vaccination or infection only to fade a few months later, memory B cells can stick around to prevent severe disease for decades. “While a natural infection may induce maturation of antibodies with broader activity than a vaccine does-;a natural infection can also kill you. A vaccine won't do that and, in fact, protects against the risk of serious illness or death from infection." // 8.10.2021

Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity. // 8.10.2021

Actually, you’re probably not in quarantine. // 8.10.2021

The ongoing COVID-19 pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been responsible for various cutaneous manifestations. Among them, chilblain-like lesions (CLL) have been found to occur more frequently. // 8.10.2021

In this review, researchers summarized the therapeutic and pathogenic role of IL-7 in patients with COVID-19 and examined the promising role of IL-7 as a vaccine adjuvant. // 7.10.2021

Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers. // 7.10.2021

Nature - An inexpensive type of portable filter efficiently screened SARS-CoV-2 and other disease-causing organisms from hospital air. // 6.10.2021

The story of ivermectin for Covid-19 continues to get even more // 7.10.2021

A new study investigated a cluster of COVID-19 infections among travelers who were likely exposed to an index patient in an airplane. // 6.10.2021

A new study, published on the medRxiv* preprint server, suggested that selective pressures induced by the administration of monoclonal antibodies (Bamlanivimab) may require increased genomic surveillance to identify and control the spread of therapy-induced variants. // 6.10.2021

A new study published on the medRxiv* preprint server focused on a patient with a persistent symptomatic viral infection for over a year. Researchers amplified sub-genomic transcripts for the E gene (sgE) using nasopharyngeal samples of the patient infected with SARS-CoV-2 over the course of 335 days. // 6.10.2021

The current study used data on the durability of immunity among evolutionarily close coronavirus relatives of SARS-CoV-2 to estimate times to reinfection. // 6.10.2021

Researchers studied the effect of enisamium on the growth and proliferation of Caco-2 and normal human bronchial epithelial cells. // 6.10.2021

Researchers published a study on the expression and functional analyses of a neutralizing mAb with identical variable domains but different constant HCs, representing IgG1-4. // 6.10.2021

Diagnoosien määrä on kuitenkin deltavariantin ja rokotusten myötä vähentynyt. // 6.10.2021

Terveyden ja hyvinvoinnin laitoksen (THL) johtava asiantuntija Mia Kontio kertoo, ettei Suomen jääminen EU- ja ETA-maiden keskiarvon alle ollut yllätys. // 6.10.2021

In a new study published on the medRxiv* preprint server, scientists have used available data on the Delta variant’s viral load to infer its infectiousness and, subsequently, estimate the reduction in its transmission brought about by surveillance testing. // 6.10.2021

Viral infections are a common cause of myocarditis. Some studies have indicated an association between COVID-19 and myocarditis. // 3.10.2021

In a new study, a collaboration of researchers from various institutes described the natural history of SARS-CoV-2 testing, which includes Ct values among patients who had tested positive multiple times, prior to the emergence of VOCs in the vaccine roll-out. In addition, the authors analyze the timescale of positivity and clinical features of the population of patients with prolonged SARS-CoV-2 positivity. // 5.10.2021

Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). // 5.10.2021

A new study discusses the role of a mucin gene enhancer on the clinical phenotype of the COVID-19. // 5.10.2021

A new study shows that up to a third of survivors in LTCFs were infected during the first year after infection. // 5.10.2021

A study aimed to understand the evolutionary and epidemiology dynamics of coronavirus diversity in animals, humans, and wildlife at ecosystem interfaces. // 5.10.2021

A simulation study explored event-level overdispersion of SARS-Cov-2 spread, utilizing real-world inputs from a large number of social gatherings. // 5.10.2021